Company intelligence
LiVeritas Biosciences, Inc.
Pioneering Agentic AI for Regulated Science
About LiVeritas Biosciences, Inc.
LiVeritas Biosciences enables biopharma companies to fast track drug research & development (R&D) process through mass spectrometry (MS) and digital transformation. We offer unparalleled sense of urgency and quality of work to empower our partners in delivering patient-centric outcomes through: • Curated analytical test packages effective in rapidly advancing drug candidates in the development pipeline including (1) drug design optimization, (2) process development and characterization, (3) accelerating novel drug candidates path to Investigational New Drug (IND) • Partner-centric software solutions that streamlines analytical operations, CMC strategies, and drug product knowledge management; and • Industry expertise with milestone focused biotech startup backgrounds grounded in big biopharma core competencies.
Verified activity
Signals from LiVeritas Biosciences, Inc.
2 published signals
Presence & Recognition
LiVeritas Biosciences, Inc. will be presenting at the 2026 CASSS – Sharing Science Solutions Mass Spec Symposium at the Hilton Washington DC/Rockville Hotel, Rockville, MD, Sept 16-18, 2026.
Reported by Lieza D.
Presence & Recognition
LiVeritas Biosciences, Inc. signed up for Early Access to its Mass Spec AI Co-Scientists at the ASMS 2026 Conference in San Diego.
Reported by Lieza D.